Tuberculosis Elimination Strategy

WHO launches plan for cheaper TB drugs


Mains Paper 3: Science & Technology | Science and Technology- developments and their applications and effects in everyday life Achievements of Indians in science & technology; indigenization of technology and developing new technology

From UPSC perspective, the following things are important:

Prelims level: EoI, TB drugs, etc.

Mains level: The decision will help in making low cost TB medicines.

Invitation for Pharmaceutical Companies

  1. The WHO has invited pharmaceutical companies around the world to submit proposals to manufacture affordable versions of newer medicines for treatment of drug resistant tuberculosis
  2. WHO has now requested drug makers to submit an Expression of Interest (EoI) for Bedaquiline and Delaminid, two new-generation drugs, recommended for drug resistant-TB
  3. Under WHO norms, drugs submitted upon such requests and complying with its standards are included in a list for procurement by the UN and other organisations

What is the aim behind this invitation?

  1. The aim is to replicate the success of addressing the HIV epidemic
  2. For example, competition among Indian drug producers had then brought down the price of HIV medicines by 99% from $15,000 per patient per year to less than a dollar a day
  3. Also, one of the aims of is to ensure that a greater number of manufacturers are supplying quality medicines, which, in turn, means a more competitive market and more affordable prices

India’s condition

  1. India has nearly 1.3 lakh DR-TB patients, the most in the world, but the Health Ministry gets only 10,000 doses of Bedaquiline and 400 doses of Delaminid
  2. The medicines are obtained as donations from Janssen (US) and Otsuka Pharmaceuticals (Japan), the respective manufacturers
Notify of
Inline Feedbacks
View all comments